Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Tiltan Pharma logo — company profile

Tiltan Pharma

Founded 2006 Israel Israel 7 employees Venture round Biotechnology, Health Care +1

General Information

Company Name Tiltan Pharma
Founded Year 2006
Location Israel Israel
Employees 7
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Tiltan Pharma. To contact Tiltan Pharma, visit tiltanpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tiltan Pharma compare?

A PDF of Tiltan Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tiltan Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tiltan Pharma

Tiltan Pharma is a clinical stage biotechnology company headquartered in Israel, founded in 2006. The company focuses on developing novel combinations of known drugs for cancer treatment, utilizing a multi-faceted approach with agents targeting different mechanisms-of-action. Their leading product, TL-118, is a unique orally administered drug combination with demonstrated safety, efficacy, and broad applicability across various cancers. Currently, Tiltan Pharma is concluding a Phase 2 clinical trial evaluating TL-118's safety and efficacy in combination with Standard-of-Care for metastatic pancreatic cancer. The company's strategy of leveraging approved drugs for combination therapies provides a fast regulatory pathway and strong patent protection. Notably, their proprietary formulations and treatment regimens contribute to the novelty of their drug combinations, securing a competitive edge in the market. Tiltan Pharma's innovative approach to cancer treatment and promising clinical trial results position them as a potentially lucrative investment opportunity in the biotechnology and healthcare industries.

No funding data available for Tiltan Pharma yet.

Tiltan Pharma Alternatives & Competitors

View All Alternatives
Tiltan Pharma vs
PanTher Therapeutics
PanTher Therapeutics United States

A Quantum Leap Forward in the Fight Against Cancer

Non Equity Assistance
16 employees
Biotechnology, Health and Wellness
Tiltan Pharma vs
TRIO Pharmaceuticals, Inc.
TRIO Pharmaceuticals, Inc. United States

Outsmart Cancer

Seed
10 employees
Biotechnology, Health Care
Tiltan Pharma vs
Altor Bioscience Corporation
Altor Bioscience Corporation

Altor has developed a unique proprietary technology for producing biologically active, soluble TCR m...

Private Equity
1 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Tiltan Pharma

Tiltan Pharma is a clinical stage biotechnology company focused on the development of novel and synergistic combinations of known drugs for the treatment of cancer. The Company has pioneered a transformational therapeutic approach based on a multi-faceted intervention through the combination of agen...
Tiltan Pharma was founded in 2006.
Tiltan Pharma is headquartered in Israel.
Tiltan Pharma operates in Biotechnology, Health Care and Health and Wellness.
Tiltan Pharma has approximately 7 employees.
Top alternatives and competitors to Tiltan Pharma include PanTher Therapeutics, TRIO Pharmaceuticals, Inc., Altor Bioscience Corporation, AbilityPharma, Lyra Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tiltan Pharma and PanTher Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tiltan Pharma, https://bouncewatch.com/company/tiltan-pharma, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout